What is the recommended treatment for a 27‑week pregnant woman with a one‑week history of varicella‑zoster virus infection affecting the right T4 dermatome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Herpes Zoster in a 27-Week Pregnant Woman

Oral acyclovir should be initiated immediately for this pregnant woman with herpes zoster affecting the T4 dermatome. 1, 2

Recommended Treatment Regimen

Oral acyclovir is the treatment of choice for uncomplicated herpes zoster during pregnancy. 1 While the specific dosing is not detailed in pregnancy-specific guidelines, standard treatment for herpes zoster typically involves higher doses than for HSV infections. 3

  • Start oral acyclovir as soon as possible to accelerate healing of skin lesions, alleviate pain, and reduce both duration and severity of symptoms 1, 2
  • Treatment should be initiated even though the rash has been present for one week, as pregnant women may experience prolonged healing and are at risk for complications 3

Safety Considerations in Pregnancy

Acyclovir is considered safe during pregnancy:

  • No pattern of adverse pregnancy outcomes has been reported after acyclovir exposure 3
  • The primary goal is to prevent maternal complications rather than fetal effects, as herpes zoster reactivation during pregnancy typically does not cause harm to the fetus or lead to birth defects 1, 2
  • Maternal herpes zoster does increase maternal morbidity and requires treatment to prevent complications 1, 2

When to Consider IV Acyclovir

High-dose IV acyclovir should be reserved for:

  • Signs of dissemination beyond the single dermatome 3
  • Development of complications such as pneumonitis, hepatitis, or encephalitis 2
  • Severe or progressive disease despite oral therapy 3

Oral therapy is appropriate for localized dermatomal zoster as described in this case, but the patient should be monitored closely for signs of dissemination or visceral involvement 3

Important Clinical Pitfalls

Monitor for complications that increase maternal morbidity:

  • Subacute herpetic neuralgia and post-herpetic neuralgia are the most common complications 1
  • Zoster ophthalmicus if lesions approach the eye 1
  • Secondary bacterial superinfection of skin lesions 3
  • Disseminated disease (rare but serious) 1, 2

Do not delay treatment even though the rash has been present for one week—pregnant women with immunologic changes may have prolonged disease course and benefit from antiviral therapy 3, 1

Fetal Considerations

Reassure the patient that:

  • Herpes zoster reactivation during pregnancy rarely causes fetal infection 1, 2
  • Approximately 20% of newborns may develop neonatal or infantile herpes zoster without complications, but this is generally benign 2
  • The primary concern is maternal health and preventing maternal complications 1, 2

This is distinct from primary varicella infection (chickenpox) during pregnancy, which carries significant fetal risks including congenital varicella syndrome—herpes zoster reactivation does not carry these same fetal risks 2

References

Research

Management of herpes zoster (shingles) during pregnancy.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.